John C. Pecknold

2.1k total citations
48 papers, 1.5k citations indexed

About

John C. Pecknold is a scholar working on Experimental and Cognitive Psychology, Psychiatry and Mental health and Pharmacology. According to data from OpenAlex, John C. Pecknold has authored 48 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Experimental and Cognitive Psychology, 22 papers in Psychiatry and Mental health and 13 papers in Pharmacology. Recurrent topics in John C. Pecknold's work include Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (30 papers), Treatment of Major Depression (10 papers) and Mental Health Research Topics (10 papers). John C. Pecknold is often cited by papers focused on Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (30 papers), Treatment of Major Depression (10 papers) and Mental Health Research Topics (10 papers). John C. Pecknold collaborates with scholars based in Canada, United States and Australia. John C. Pecknold's co-authors include David McClure, Richard P. Swinson, F. Engelsmann, Jambur Ananth, Teresa Allan, Eva Libman, Ilana P. Spector, John R. Walker, Roger Lane and Rudradeo C. Bowen and has published in prestigious journals such as American Journal of Psychiatry, Biological Psychiatry and The British Journal of Psychiatry.

In The Last Decade

John C. Pecknold

47 papers receiving 1.4k citations

Peers

John C. Pecknold
Karl Rickels United States
H.G.M. Westenberg Netherlands
T W Uhde United States
Peter D. Londborg United States
Nicholas DeMartinis United States
John C. Pecknold
Citations per year, relative to John C. Pecknold John C. Pecknold (= 1×) peers L. Ravizza

Countries citing papers authored by John C. Pecknold

Since Specialization
Citations

This map shows the geographic impact of John C. Pecknold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John C. Pecknold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John C. Pecknold more than expected).

Fields of papers citing papers by John C. Pecknold

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John C. Pecknold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John C. Pecknold. The network helps show where John C. Pecknold may publish in the future.

Co-authorship network of co-authors of John C. Pecknold

This figure shows the co-authorship network connecting the top 25 collaborators of John C. Pecknold. A scholar is included among the top collaborators of John C. Pecknold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John C. Pecknold. John C. Pecknold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Spector, Ilana P., John C. Pecknold, & Eva Libman. (2002). Selective attentional bias related to the noticeability aspect of anxiety symptoms in generalized social phobia. Journal of Anxiety Disorders. 17(5). 517–531. 56 indexed citations
2.
Pecknold, John C.. (1997). A Risk-Benefit Assessment of Buspirone in the Treatment of Anxiety Disorders. Drug Safety. 16(2). 118–132. 22 indexed citations
3.
Leyton, Marco, Claude Bélanger, Serge Beaulieu, et al.. (1996). Cardiovascular, neuroendocrine, and monoaminergic responses to psychological stressors: Possible differences between remitted panic disorder patients and healthy controls. Biological Psychiatry. 40(5). 353–360. 21 indexed citations
4.
Iny, Linda J., et al.. (1994). Studies of a neurochemical link between depression, anxiety, and stress from [3H]imipramine and [3H]paroxetine binding on human platelets. Biological Psychiatry. 36(5). 251–291. 68 indexed citations
5.
Pecknold, John C.. (1993). Discontinuation reactions to alprazolam in panic disorder. Journal of Psychiatric Research. 27. 155–170. 24 indexed citations
6.
Pecknold, John C., et al.. (1993). Gepirone and the Treatment of Panic Disorder. Journal of Clinical Psychopharmacology. 13(2). 145???148–145???148. 22 indexed citations
7.
Rifkin, Arthur, John C. Pecknold, Richard P. Swinson, et al.. (1990). Sequence of improvement in agoraphobia with panic attacks. Journal of Psychiatric Research. 24(1). 1–8. 9 indexed citations
8.
Pecknold, John C., et al.. (1990). Sleep studies and neurochemical correlates in panic disorder and agoraphobia. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 14(5). 753–758. 17 indexed citations
9.
Lesser, Ira M., Robert T. Rubín, Arthur Rifkin, et al.. (1989). Secondary depression in panic disorder and agoraphobia. II. Dimensions of depressive symptomatology and their response to treatment. Journal of Affective Disorders. 16(1). 49–58. 22 indexed citations
10.
Pecknold, John C., et al.. (1989). Trimipramine, anxiety, depression and sleep. Drugs. 38(Supplement 1). 25–31. 6 indexed citations
11.
Pecknold, John C.. (1988). Alprazolam in Panic Disorder and Agoraphobia: Results From a Multicenter Trial. Archives of General Psychiatry. 45(5). 429–429. 155 indexed citations
12.
Pecknold, John C.. (1988). Serotonin uptake in panic disorder and agoraphobia. Neuropsychopharmacology. 1(2). 173–176. 25 indexed citations
13.
Pecknold, John C., Hsin‐An Chang, D. Fleury, et al.. (1987). Platelet imipramine binding in patients with panic disorder and major familial depression. Journal of Psychiatric Research. 21(3). 319–326. 13 indexed citations
14.
Pecknold, John C.. (1987). Behavioural and combined therapy in panic states. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 11(2-3). 97–104. 1 indexed citations
15.
Swinson, Richard P., et al.. (1987). Benzodiazepine dependence. Journal of Affective Disorders. 13(2). 109–118. 13 indexed citations
16.
Pecknold, John C. & D. Fleury. (1986). Alprazolam-induced manic episode in two patients with panic disorder. American Journal of Psychiatry. 143(5). 652–653. 20 indexed citations
17.
Pecknold, John C., et al.. (1982). Does Tryptophan Potentiate Clomipramine in the Treatment of Agoraphobic and Social Phobic Patients?. The British Journal of Psychiatry. 140(5). 484–490. 40 indexed citations
18.
Solyom, Carol, L. Solyom, Y.D. Lapierre, John C. Pecknold, & L. L. Morton. (1981). Phenelzine and exposure in the treatment of phobias.. PubMed. 16(3). 239–47. 66 indexed citations
19.
Lehmann, H. E., et al.. (1976). A double-blind comparative clinical trial with maprotiline (Ludiomil) and imipramine in newly-admitted depressed patients.. PubMed. 19(4). 463–8. 6 indexed citations
20.
Pecknold, John C., et al.. (1975). A clinical trial with nomifensin, a new antidepressant drug.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 11(4). 304–8. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026